GlassScriptPhysician profile
Jackie A Syme
NPI 1760476105
$1,922.45
in general payments reported to CMS, 2019-2025
17 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.11 · 2024: $829 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $722.22 | 2024-2025 | |
| Eisai INC. | $263.72 | 2024-2025 | |
| Argenx US, INC. | $196.30 | 2025 | Vyvgart Hytrulo |
| Lilly USA, LLC | $145.67 | 2024-2025 | Amyvid, Kisunla, Emgality |
| Lundbeck LLC | $134.59 | 2024-2025 | Vyepti |
| Pfizer INC. | $127.64 | 2024-2025 | |
| Celgene Corporation | $63.17 | 2024-2025 | Zeposia |
| Abbvie INC. | $44.52 | 2024 | |
| Vanda Pharmaceuticals INC. | $37.18 | 2024-2025 | Ponvory |
| Jazz Pharmaceuticals INC. | $34.97 | 2024 | |
| Amneal Pharmaceuticals LLC | $30.07 | 2024 | Ongentys, Rytary |
| Life Molecular Imaging LTD | $28.98 | 2025 | Neuraceq |
| Harmony Biosciences LLC | $24.91 | 2025 | |
| Emd Serono, INC. | $19.96 | 2024 | |
| Acorda Therapeutics, INC | $18.71 | 2024 | Ampyra, Inbrija |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Springworks Therapeutics, INC. | $16.73 | 2025 | Gomekli |
| Teva Pharmaceuticals USA, INC. | $13.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackie Syme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.